Preclinical studies on mice have shown that gut microbiota could stimulate CD8+ T cells and Th1 activation by commensal bacteria, influencing cancer responses [87], while exposure to antibiotics could attenuate the effects of cancer therapy [88]. Here, CD8A is linked to cancer.